SCHEMBL23264239

SCHEMBL23264239

CN(Cc1ccc(Cl)cc1)S/C(=N\C=O)NC(=O)c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ TMEM97 Q5BJF2 3/20 0.41
▸ SIGMAR1 Q99720 3/20 0.41
▸ ALDH1A1 P00352 5/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ LMNA P02545 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ SCN5A Q14524 1/20 0.40
▸ SCN2A Q99250 1/20 0.40
▸ POLB P06746 2/20 0.39
▸ GAA P10253 2/20 0.39
▸ CTDSP1 Q9GZU7 1/20 0.39
▸ HTT P42858 2/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22909931 0.84 IDO1 (0.39) SMN1; SMN2TMEM97SIGMAR1ALDH1A1KDM4E
SCHEMBL22909902 0.71 IDO1 (0.39) SMN1; SMN2TMEM97SIGMAR1ALDH1A1KDM4E
SCHEMBL15047786 0.64 MAPT (0.67) SMN1; SMN2ALDH1A1KDM4ELMNAMAPT
SCHEMBL14859304 0.63 RAB9A (0.56) SMN1; SMN2TMEM97SIGMAR1ALDH1A1KDM4E
SCHEMBL19389734 0.62 LSS (0.58) TMEM97SIGMAR1ALDH1A1L3MBTL1GAA
SCHEMBL10475186 0.61 ALDH1A1 (0.57) SMN1; SMN2ALDH1A1KDM4ELMNAMAPT
SCHEMBL13273458 0.61 ALDH1A1 (0.57) SMN1; SMN2ALDH1A1KDM4ELMNAMAPT
SCHEMBL5060811 0.61 ALDH1A1 (0.57) SMN1; SMN2ALDH1A1KDM4ELMNAMAPT
SCHEMBL79445 0.61 HDAC2 (0.64) SMN1; SMN2ALDH1A1KDM4ELMNAMAPT
SCHEMBL28959084 0.61 MAPT (0.61) SMN1; SMN2ALDH1A1KDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021074646-A1 NEW FORMULATIONS BALTICGRUPPEN BIO AB (SE) 2021-04-22 — — WO disclosed
Send feedback